Artificial tears are over-the-counter lubricating eye drops designed to mimic natural tears, providing relief from dry eye syndrome by supplementing the tear film's aqueous, lipid, or mucin layers.
Artificial Tears Market Overview and Growth
The global artificial tears market is poised for significant growth over the next decade. Valued at US$ 2.98 billion in 2023, the market is projected to reach US$ 4.85 billion by 2031, registering a CAGR of 7.2% during the forecast period of 2024–2031. The growing prevalence of dry eye conditions, lifestyle changes, and an aging population are key factors driving market expansion.
Artificial tears are widely used to treat dry eyes, relieve discomfort caused by visual fatigue, and maintain moisture for contact lens users. Dry eye incidence is particularly high in developed regions, driven by environmental factors, prolonged screen exposure, and other lifestyle habits. According to the National Health and Wellness Survey conducted in the US in 2020, approximately 16.4 million people were diagnosed with dry eye. Among people aged 18–34 years, prevalence increased by 2.7%, while the rate was 18.6% among older adults. Women were more affected than men, with prevalence rates of 8.8% and 4.5%, respectively. Similar trends are observed across Europe and the Asia Pacific, highlighting a strong market need for artificial tear products.
Market Drivers
- Growing Older Population
The global geriatric population is expanding rapidly. By 2050, one in six people worldwide will be over 65 years of age, compared to one in eleven in 2019. In Europe and North America, one in four people is projected to be over 65 by 2050. Additionally, the population aged 80 and above is expected to increase from 143 million in 2019 to 426 million by 2050. Aging significantly contributes to eye degeneration, making older adults more susceptible to dry eye conditions. This demographic trend is encouraging manufacturers to focus on innovative artificial tear products tailored for the geriatric population, further driving market growth.
- Increasing Number of Industrial Developments
The artificial tears market has witnessed several strategic product launches and technological innovations. For example:
- In March 2020, Grafton Optical launched I-DROP MGD Viscoadaptive Tears, a preservative-free solution designed for patients with Meibomian Gland Dysfunction.
- Alcon introduced SYSTANE HYDRATION Preservative-Free Lubricant Eye Drops to relieve dryness and protect against further irritation.
- In October 2019, Allergan launched Refresh Relieva lubricant eye drops, strengthening its market position.
- Sun Pharma launched CEQUA in India in April 2023 to address dry eye disease (DED).
These developments highlight a trend toward advanced, preservative-free, and therapeutic formulations, offering lucrative opportunities for market participants.
Download PDF Copy- https://www.theinsightpartners.com/sample/TIPRE00004073
Market Segmentation
By Type:
- Cellulose derived tears
- Glycerin derived tears (largest market share in 2023)
- Oil-based emulsion tears
- Polyethylene glycol-based tears
- Propylene glycol-based tears
- Sodium hyaluronate-based tears
By Delivery Mode:
- Eye drops
- Ointments
By Application:
- Dry eyes treatment (largest segment in 2023)
- Contact lenses moisture
Regional Insights
North America dominates the market, with the US being the largest contributor. Increasing prevalence of dry eye, growing healthcare expenditure, and widespread availability of advanced eye care products are driving growth. According to JAMA Internal Medicine, the US government spends over US$ 2 billion annually on dry eye treatment. Europe and the Asia Pacific also represent high-growth markets due to aging populations and rising awareness about eye care.
Key Players
The artificial tears market is highly competitive, with key players focusing on product innovation, mergers, and regional expansion. Some of the leading companies include:
- Johnson Services, Inc.
- Alcon Inc.
- OASIS Medical
- AbbVie Inc.
- Bayer AG
- Prestige Consumer Healthcare Inc.
- Santen Pharmaceutical Co., Ltd.
- Bausch Health Companies Inc.
- Akorn Incorporated
- Aurolab
Future Outlook
The future of the artificial tears market looks promising, driven by continued innovation and increased awareness of eye health. Advances in formulation technology, including preservative-free and long-lasting lubricating drops, will enhance product efficacy and user compliance. Additionally, growing smartphone use, increased screen time, and rising prevalence of lifestyle-related eye conditions are expected to sustain strong demand. Expanding markets in Asia Pacific, Latin America, and the Middle East, along with strategic partnerships and new product launches, will provide ample opportunities for industry growth through 2031 and beyond.
Related Reports-
